These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26108913)

  • 21. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
    Dixit R; Khandaker G; Ilgoutz S; Rashid H; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):34-45. PubMed ID: 23675925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuraminidase inhibitors were widely used in the UK during the 2009 influenza A(H1N1) pandemic.
    Nguyen-Van-Tam JS; Nicholson KG
    J Clin Virol; 2011 Feb; 50(2):183. PubMed ID: 21112812
    [No Abstract]   [Full Text] [Related]  

  • 23. Oseltamivir pharmacology in young children: a commentary.
    Kamal MA
    Infect Disord Drug Targets; 2013 Feb; 13(1):2-5. PubMed ID: 23675921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.
    Svensson T; Granath F; Stephansson O; Kieler H
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1030-4. PubMed ID: 21774030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.
    Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
    PLoS One; 2012; 7(9):e43491. PubMed ID: 22984431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study claiming Tamiflu saved lives was based on "flawed" analysis.
    Kmietowicz Z
    BMJ; 2014 Mar; 348():g2228. PubMed ID: 24646608
    [No Abstract]   [Full Text] [Related]  

  • 28. Influenza viruses resistant to neuraminidase inhibitors.
    Nitsch-Osuch A; Brydak LB
    Acta Biochim Pol; 2014; 61(3):505-8. PubMed ID: 25195142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
    Kawai N; Ikematsu H; Tanaka O; Matsuura S; Maeda T; Yamauchi S; Hirotsu N; Nishimura M; Iwaki N; Kashiwagi S
    J Infect Chemother; 2011 Jun; 17(3):375-81. PubMed ID: 21120678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical use of approved influenza antivirals: therapy and prophylaxis.
    Ison MG
    Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):7-13. PubMed ID: 23279892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of neuraminidase inhibitors for severe influenza.
    Fry AM
    Lancet Respir Med; 2014 May; 2(5):346-8. PubMed ID: 24815800
    [No Abstract]   [Full Text] [Related]  

  • 32. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
    Renaud C; Kuypers J; Englund JA
    J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(18):497-500. PubMed ID: 19444154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of influenza resistance to the neuraminidase inhibitors.
    Thorlund K; Awad T; Boivin G; Thabane L
    BMC Infect Dis; 2011 May; 11():134. PubMed ID: 21592407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized double-blind controlled study of laninamivir compared with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases.
    Watanabe A
    J Infect Chemother; 2013 Feb; 19(1):89-97. PubMed ID: 22907567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
    Baz M; Abed Y; Papenburg J; Bouhy X; Hamelin ME; Boivin G
    N Engl J Med; 2009 Dec; 361(23):2296-7. PubMed ID: 19907034
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.
    Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M
    Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
    Jefferson T; Jones M; Doshi P; Del Mar C; Dooley L; Foxlee R
    Cochrane Database Syst Rev; 2010 Feb; 2011(2):CD001265. PubMed ID: 20166059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do we need a replacement medication for influenza with good efficacy?
    Arastoo M; Khorshid HR
    Daru; 2014 Dec; 22(1):84. PubMed ID: 25523212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.